Skip to content

Enhancing mindfulness and compassion through an ayahuasca-inspired formulation containing N,N-DMT and harmine: A randomized controlled trial in healthy subjects.

Helena D Aicher, Ilhui A Wicki, Daniel Meling, Michael J Mueller, Dario A Dornbierer, Milan Scheidegger

Journal of psychopharmacology (Oxford, England) June 19, 2025 DOI: 10.1177/02698811251344689 via PubMed

Summary

AI-generated from the abstract

A single dose of an ayahuasca-inspired DMT/harmine formulation increased mindfulness and compassion in 31 healthy participants one day after administration. The randomized, double-blind, placebo-controlled trial found significant effects on mindfulness, self-compassion, and compassion with others, with larger effects in participants who reported higher sensitivity to the drug. These results suggest the formulation may have therapeutic potential for enhancing traits relevant to mood disorders, though further research in clinical settings is needed.

Study at a glance

Characteristics Randomized, double-blind, placebo-controlled within-subjects design Peer reviewed
Sample size 31
Population Healthy participants
Interventions DMT/harmine formulation harmine + placebo placebo only
Duration 1 day post-treatment
Topics Ayahuasca DMT Meditation
Keywords N,N-DMT Harmine Psychedelics
Citations 2
Key finding A DMT/harmine formulation significantly increased mindfulness and compassion one day after administration in healthy subjects.

Abstract

Mindfulness and compassion are therapeutically relevant and can be increased through different forms of meditation practices. However, meditation practice needs time and commitment. These resources are often limited in patients with mood disorders. Therefore, efficacious remedies that increase mindfulness and compassion could provide therapeutic options. This study aimed to investigate the relationship between psychedelic experiences induced by an ayahuasca-inspired N,N-dimethyltryptamine (DMT)/harmine formulation on mindfulness and compassion in healthy subjects. This study applies a randomized, double-blind, placebo-controlled within-subjects design in a laboratory setting with 31 healthy participants. Each subject received a formulation comprising DMT + harmine, harmine + placebo, and placebo only on three different study days. Primary outcomes were mindfulness (MINDSENS) and compassion (SOCS). A significant effect of the drug on mindfulness (p < 0.05, F = 3.41), self-compassion (SOCS-S; p < 0.01, F = 7.53), and compassion with others (SOCS-O; p < 0.05, F = 3.37) 1 day post-treatment was found. Significant differences between the high- and low-sensitivity groups were found for mindfulness (p < 0.05, F = 6.54), self-compassion (p < 0.05, F = 4.21), and compassion with others (p < 0.05, F = 4.42). In line with previous studies on traditional botanical ayahuasca, our findings support the notion that the DMT/harmine formulation might have therapeutic potential through its ability to acutely enhance mindfulness and compassion. Continuing studies in therapeutic settings are needed to further elucidate the mechanisms of action of ayahuasca-inspired formulations.

Explore topics

Comments

No comments yet.

Log in to comment